Topics & People

The marketing of drugs directly to consumers, which the FDA is cracking down on to prevent misleading impressions and ensure a fair balance of information.

Foods such as cellular meat or proteins made via fermentation, which the FDA regulates. Makary's administration is closing loopholes in the 'generally recognized as safe' (GRAS) process that affects these products.

A type of immunotherapy where a patient's T-cells are engineered to attack diseases like cancer and autoimmune conditions. It is described as an amazing and mind-boggling class of drugs.

Advanced medical treatments modifying genes or using cells to rejuvenate the body.

Former director of the National Institute of Allergy and Infectious Diseases, mentioned as part of the old guard and culture at the NIH.

The community of microorganisms in the body, which was altered positively by psilocybin use.

A category of non-prescription medications. The FDA aims to move more drugs into this category to increase price transparency, competition, and access while bypassing PBMs.

Generic versions of biologic drugs. The FDA is cutting the red tape for their approval to increase competition and lower drug prices.

A class of expensive medications manufactured using a cell line. The FDA is working to lower their prices by accelerating the approval of their generic equivalents, biosimilars.

A policy pursued by the Trump administration to ensure the US pays the lowest price for pharmaceuticals among developed nations, aiming to radically lower drug costs.

Centers for Disease Control and Prevention.

A new, smaller, and prioritized list of recommended childhood vaccines (38 doses) created by the FDA to rebuild public trust and combat vaccine hesitancy.